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INTRODUCTION 
Peptic  ulcer  disease  is  a  common  ailment  in patients  suffering 
from  symptoms  of  dyspepsia. Duodenal  ulcers  nearly  constitute  one  
third  of  all  cases  of  peptic  ulcer  disease .It  is  characterised  by  a   
defined  defect  in  the  mucosa  which  extends  into  muscular  propria  
as  well. 
The   common  causes  of  PUD  are NSAID  abuse  , decreased   
mucosal  resistance  and  H.pylori  infection.H.pylori infection and 
hyperchlorhydria can induce stomach and duodenum.  It has to be 
documented whether H.pylori  produces any change in stomach wall 
other than the ulcer site. Infection by H.pylori can occur in gastric 
mucosal surface  as well as mucosa in proximal duodenum.   
 Recent studies ,plan to eradicate   H.pylori, in an attempt  to heal 
peptic ulcer disease have given promising results and proves  a clear 
correlation between Helicobacter pylori infection and peptic ulcer 
diseases. 
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AIMS   AND   OBJECTIVES 
1. To study the changes in stomach wall at sites other than  the ulcer 
site in PUD. 
2. To correlate the association of stomach wall changes with 
H.pyloric infection. 
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REVIEW  OF LITERATURE 
MURALTO  was the one who found out  the presence of duodenal 
ulcers in 1688 in a autopsy 
CRISP,presented  the first paper regarding perforation in peptic  
ulcers in 1843.Treatment  for perforation had been a great hallmark in 
general surgery practising since 100 years. 
JOHN LYKOUDIS, a physician  from Greece  in 1958 treated 
stomach ulcers with medications 
H.PYLORI was discovered  by scientists from Australia named 
ROBIN WARREN and  BARRY J MARSHALL in 1982 that it was the 
reason for ulcers 
In 1997 centers for disease control for prevention described the 
association of H.pylori with gastritis and ulcers  
NOBEL PRIZE for H.pylori  as a cause for peptic ulcer disease 
was awarded to professor  MARSHALL  in 2005. He belonged to 
KAROLINSKA INSTITUTE IN STOCKHOLM 
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ANATOMY OF STOMACH  
Stomach is the most  vascularised part of gastrointestinal  tract 
among all organs. Stomach is divided into  
Fundus  
Body 
Lesser  curvature 
Greater curvature  
Antrum  
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ARTERIAL SUPPLY 
Stomach derives its blood supply mainly from the celiac axis and 
its branches. The branches  are 
The right gastric artery 
The left gastric artery 
The right gastroepiploic artery 
The left gastro epiploic artery 
The short gastric arteries 
The left gastric artery is the largest branch among all arteries. The 
right and left gartric arteries together form a anastamosis around the 
lesser curvature .  The right and left epiploic arteries form arich arcade 
around the lesser curvature.The left gatric artery divides into a ascending 
and descending  branch 
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Venous drainage 
1. Left gastric vein 
2. right gastric vein 
Both veins drain into portal vein. 
         3.The right gastroepiploic vein drains into the superior mesenteric 
vein. 
         4. Left gastroepiploic vein drains into inferior mesenteric vein 
Lymphatic drainage 
Gastric lymphatics parallel the blood vessels. 
1.The cardiac nodes -  along left gastric and celiac axis 
     2.Lesser curvature  -  nodes along the right gastric 
     3. Distal greater curvature  -   nodes along right gastroepiploic         
vein 
     4.Proximal greater curvature  -  nodes along the left gastroepiploic  
vein in splenic hilum. 
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LYMHPHATIC DRAINAGE OF STOMACH 
The lymphatic system of stomach is very important as in gastric  
carcinomas the metastatic spread is mainly through lymphatics .  The 
operative procedures are  also mainly concerned about removing the 
nodes that have been  involved in the carcinoma.  Nodal spread is very 
important in determining the prognostic value of the disease. 
Nerve supply 
The extrinsic and intrinsic innervations of the stomach have an 
important role in gastric secretory and motor function.  The vagus 
provides parasympathetic innervations to the stomach and acetylcholine is 
the important  neurotransmitter. 
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 Near the junction anterior vagus sends branches to liver and 
continues along the lesser curvature as anterior nerve of LATARJET.  
These nerves  send segmental branches to the body of stomach before 
they terminate near  angularis incisura as crow’s pet in antipyloric region.  
The posterior branch sends branches to posterior fundus and is called 
CRIMINAL NERVE OF GRASSI AUERBACH’S  myenteric plexus and 
meissner submucosa plexus are found in muscularis and submcosa. 
The extrinsic sympathetic nerve supply to the stomach  originate at 
spinal levels T5 to T10 and travels in splanchnic nerve to celiac ganglia 
                               
 
 
 
9 
 
 
VAGOVAGAL REFLEX 
The vagovagal  reflex plays a important role  in secretion of  acid. 
This reflex is mediated by the local afferent and efferent fibres of this 
nerve through the dorsal vagal nucleus found in brain. It becomes active 
when bolus enters the stomach and produces  distension of stomach to 
accomdate the food that enters via esophagus.The stimulation of 
mechanical receptors  found in the body send impulses via afferents and 
result is activation of  post ganglionic  muscuranic receptors which 
secrete acetylcholine that stimulates secretion of hcl by parietal cells and 
ecl cells to secrete histamine . Histamine is a strong inducer of gastrin 
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secretion. This  vagal stimulation also activates the peptidegenic neurons 
which are responsible for production of gastrin releasing polypeptide. 
Delta cells  which secrete somatostatin is also inhibited  by this vagal 
stimulation resulting in increased release of gastrin. 
The parasympathetic nerves carrying both afferent And  efferent  
nerves recognise the stretch receptors and Osmoreceptors and carry 
impulses to dorsal vagal complex and return is carried by way of vagal 
nerves and spread to right 2/3 of transverse colon. 
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HISTOLOGY 
                         
Four distinct layers 
1.mucosa 
2.submucosa 
3.muscularis propria 
4.serosa 
 
12 
 
Mucosa is lined by columnar epithelial cells .  It is glandular in 
type.  A scanning electron micrograph shows a smooth mucosal plane 
punctuated by openings of gastric glands.  The glands are lined by 
different types of epithelial cells depending upon their location in 
stomach.  Endocrine cells are present in the gastric glands.   
Gastric gland consists of  
       1.    Progenitor cells at base of glands. 
2.   Mucus secreting epithelial cells that secrete bicarbonate and 
Prevents stomach from injury due to acid, pepsin and 
ingested irritants. 
       3. Cheif cells- secrete pepsinogen. 
      4. Parietal cells- secrete hcl 
      5.  Enterochromaffin cells – secrete histamine. 
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Physiology of acid secretion 
Hcl hastens both physical and biochemical breackdown of ingested 
food. In acidic environment pepsin and acid facilate proteolysis . gastric 
acid inhibits ingested pathogen. 
 The parietal cell is stimulated to secrete acid when its receptor is 
stimulated by acetylcholine( from vagal fibres, gastrin (from d cells) or 
histamine ( from ecc cells) .  the enzyme H+ K+ atpase is the proton 
pump.  It is contained within te intracellular tubulovesicles and is the 
common pathway for gastric acid secretion.  The normal human stomach 
contain approximately 1 billion parietal cells and entire gastric acid 
production is proportional to parietal cells in man. 
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The major role of acid producing capacity  of both acetylcholine 
and  gastrin are regulated by histamine release from the mucosal ecl cells. 
That is why  histamine  2 receptor antagonists are such effective inhibitor 
of acid secretion. The mucosal cells produce  somatostatin which is an 
important regulator of acid secretion. 
Somatostatin decreases  histamine release from ecl cells and  
gastric  glands.  The action of  D cells is abolished by pylori infection  
and this finally lead  to increased acid producing response. 
The most potent physiologic stimulus for production  pepsinogen 
secretion from chief cells is ingestion of food.  Acetylcholine is the  
important mediator.   
Somatostatin decreases pepsinogen secretion.  Pepsinogen is 
broken down to  active pepsin enzyme in an acid environment  2.15  ph 
and inactive at ph>5  
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Gastric mucosal barrier 
Components 
1. Mucosa barrier 
2. Bicarbonate secretion 
3. Epithelial barrier 
Hydrophobic phospholipids 
Tight junction 
Restitution 
4. Microcirculation 
5. Afferent  relay neurons. 
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Mediators 
Prostaglandins 
          Nitric oxide 
Epidermal growth factor 
Calcitonin gene related peptide 
Hepatocytic growth factor 
Histamine 
          Gastrin releasing peptide 
“Barrier destroyers” such as bile or aspirin lead to high diffusion of 
hydrogen ions from the lumen into the lamina propria and submucosa  
leading  to gross ulceration. 
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DUODENUM 
ANATOMY 
Duodenum is the proximal part of small intestine and is continuous 
proximally with the pylorus.  Its forms a  c shaped  loop around the head 
of pancreas.  In adult length is 30 cm and subdivided into four sections 
First 
    Second 
    Third 
     Fourth 
The first part of the duodenum is about 5cm long and it is right, 
upward  and backward from the pylorus.  The proximal part of duodenum 
is also referred as duodenal bulb or cap.  It is loosely attached to the liver 
by the hepatoduodenal portion of the lesser omentum.  The gastric 
duodenal artery common bile duct and portal vein is posterior and gall 
bladder is anterior to it. 
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Fig shows the four parts of duodenum and ampulla of vater  and the c 
loop of duodenum and valve conventis 
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Layers of duodenum 
 
The duodenal wall is  made of outer longitudinal and  inner circular 
muscle layer.  There are mucosal folds called plicae circularis or vulvulae 
conniventes.   
Duodenal bulk is distinguished radiographically and 
endoscopically by its smooth mucosa. 
 
 
 
 
20 
 
Vascular supply 
Based  on the embryologic origin branches of celiac trunk supply 
proximal duodenum from the celiac artery arises the common hepatic 
artery from which gastroduodenal artery rises which gives anterior and 
posterior branches.  
Venous drainage corresponds to arterial supply .  The superior 
pancreaticoduodenal vein passing between duodenum and pancreatic 
head to enter the portal vein. 
LYMPHATIC DRAINAGE 
Duodenal lymphatic drainage also corresponds to the vascular 
supply.  Small anterior and posterior duodenal lymph nodes drain into  
pancreaticoduodenal nodes.  From them lymph drains  superiorly into 
hepatic nodes or interiorly into superior  mesenteric nodes located at the 
origin of superior mesenteric artery. 
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Duodenal innervations 
As stomach duodenal innervations is  provided by sympathetic and 
parasympathetic nervous symptoms.  The preganglionic  sympathetic 
nerves cause  through the celiac and superior mesenteric ganglion with  
postganglion nerves entering the  duodenal intramural plexus.   Afferent 
plexus accompany the sympathetic neurons primarily carry fibres to 
visceral pain sensation.  Parasympathetic plexus supplied by the hepatic 
branches of the anterior vagus nerve and mesenteric nerves, synapse with 
meissner’s and auerbach plexus in the duodenum 
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Histology 
 
The duodenum differ from gastric mucosa with the drainage from 
gastric glands and pits to mucosa lined with villi surrounded by crypts of  
lieberkunn and submucosa certain characteristic brunner’s gland.  A 
single layer of epithelial cells provide interface between duodenal lumen 
and mucosa in areas of both villi and crypts deep to epithelial layer are 
contained absorptive cells, paneth cells secreting apozyme mucosal cells 
and endocrine cells. 
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PEPTIC ULCER DISEASE 
These are ulcers in the stomach  or duodenum  which may continue  
into the deeper layers of stomach wall.   They are mainly due to loss of  
balance between mucosal  defences and acid secretion PUD remains a OP 
diagnosis but  number of hospital visits and admissions have decreased  
markedly in the last  three decades due to the invention of H2  receptor d 
fiboptic endoscopy.  However the incidence of  emergencies due to peptic 
ulcer has decreased   so dramatically.   
The epidemiological changes are usually due to  some beneficial 
effect such as 
1. Decreased prevelance of H.pylori infection. 
2. Better medical therapy 
                            3.Increased ourtpatiient management 
Some appreciating factors are use of NSAIDS and aspirins in aging 
population with multiple risk factors. 
PUD is one of the most common a1 disorders having a prevalence 
rate of 2% and peaks around usually 70 years of age.  The crude mortality 
rate due to peptic ulcer disease was nearly 1.7 per 1 lakh individuals.  
24 
 
Stomach wall erosions has a increased rate of mortality    When 
compared to duodenal ulcer  since  it is mainly found in elderly patients.  
Recent data suggest that there is an increase in admission and mortality in 
old individuals due to PUD complications of  bleeding and perforation.  
This may be because of dramatic  usage  of NSAIDS and aspirin in 
elderly people. 
Pathophysiology 
A large number of factors contribute to the development of PUD 
recent studies indicate that most  of duodenal and gastric ulcer are 
produced  by H.pylori  infection and NSAID ingestion.  The final  end  
step is the ulcer formation due to breakage of gastroduodenal mucosal 
barrier.  Suppression of acid is the main form of treatment. 
It is proved that h.pylori  leads to ulcer formation  by increase in 
acid secretion and damage to mucosa by damaging  SEC.  Duodenal 
disease is usually due to high  acid peptic  action in the mucosa whereas 
gastric ulcer has been due to  weakening of mucosal defences in the face 
of normal acid activity. 
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Decreased mucosal defences play an important role in many ulcers 
Example: DU ulcer in patients not infected with hpylori individuals 
on NSAIDS.   
Person with  category  I gastric ulcer with acid decrease in acid 
secretion High  corrosive  action  of acid may produce ulcer with normal 
defense mechanism 
Example:  DU ulcer in zollinger Ellison syndrome  
Gastric ulcer in outlet destruction patient, antral stasis and acid 
hypersecretion 
A variety of diseases producing peptic ulcers are 
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Gastrinomas 
     Antral  cell hyperfunction 
     Systematic mastocytosis 
Trauma 
Stress 
burns 
Helicobacter pylori: 
H.pylori has a specialised flagella.It  has an enormous  amount of 
urease.This is responsible for survival in the acidic medium of the 
stomach.Nearly 60% of the population is found to be infected with 
H.pylori. 
The sequence phenomenon of inflammation producing the 
metaplasia to dysplasia to carcinoma which is observed in oesophagus is 
found to develop in stomach due to H.pylori infection.The suppression of 
acid due to ppis and h2a antagonists on these esophagogastric 
inflammation is largely unknown.H.pylori is found to have a definitive 
role in the development of gastric lymphoma. 
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H.pylori has the enzyme urease which splits  urea producing 
ammonia and carbonate.This process creates a environment that 
facilitates survival of H.pylori in stomach. The ammonia produced in the 
stomach is damaging to the superficial epithelial  cells. There are some 
mutant strains in the H.pylori which cannot  produce urease andwill be 
unable to colonise the stomach. 
H.pylori usually lives in the mucous layer of the superficical 
epithelial cells.unfortunately the H.pylori strain without flagella are 
unable to get stirred to the apical membrane of superficial epithelial cells 
for attachment.these strains are not infective.the mechanism by which it 
causes injury to stomach maybe through alteration in the acid 
secretion.this may be due to the fact that inhibitors effect produced by 
H.pylori upon  cells that produce somatostatin,which is a antagonist of 
antral A cell secreting gastrin .Helicobacter pylori produces decreased 
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level of somatostatin by decreasing somatostatin messenger rna 
production and decreased production of  less quantity somatostatin 
producing D cells.              
The effects are  mainly produced by Helicobacter pylori action of 
antral alkanisation.Helicobacter pylori activates the release of other local 
activators and  interleukins.the end result in increased production of  
gastrin  and  increased production of acid this hypergstrenemia will lead 
to  hyperplasia of parietal cells which is found in many individuals seen 
who have DU ulcer .   
This increased production of acid leads to antral  Metaplastic 
change in the duodenum  after the pyloric region. This Metaplastic 
change  makes Helicobacter pylori an environment for colonisation  of  
the duodenum. All  patients  in this group have increased 50  fold risk of 
developing  duodenal ulcer.H.pylori colonisation produces significant 
decrease in  bicarbonate release from the duodenal mucosa.when H.pylori  
infection is successfully produced the mucosal mechanism of acid  
hypersecretion tends to normalise.   
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Other ways in which H.pylori can produce can induce the injury to 
gastroduodenal mucosa is through production of toxins namely vac A and 
cag A.This produces local increased infiltration of cytokines 
particularly(interleukins) in  affected  ulcer, infiltration of 
proinflammatory cells and increase in activation of local immune factors 
and finally leading the way to apoplasia. The final result is duodenal  
ulceration. 
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                                         Acqurisation of H.pylori 
 
                                      Colonisation in stomach 
 
                                    Somatostatin/gastrin dysregulation 
 
                                    Increased acid production 
 
                                   Gastic metaplasia in duodenum 
 
                       Dec bicarbonate               inc. inflamation 
                           secretion 
 
                                        Duodenal ulceration 
 
The evidence support  the role of Helicobacter pylori in the 
production of  PUD is very clear. Patients with Helicobacter pylori 
infection and antral  inflammation are 3 times  more favourable  to 
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develop the disease  when compared to  individuals without  infecton 
nearly 92% patients  with duodenal ulcer and 70% patients with gastric 
ulceration have been infected with Helicobacter pylori  infection. 
It is evident  from many of the  randomised prospective studies  
that  treatment of pylori infection can produce an alteration in the  natural 
course  of PUD. The complete cure  of pylori also  brings down the 
repeated attacks  of PUD  in nearly 75% of  individuals  on treatment with 
a course of suppressive acid  therapy to nearly  < 19% in individuals  
treated  with a course of  anti Helicobacter pylori  regimen. This clearly 
states that H.pylori  eradication can  markedly  decrease the  incidence of 
peptic  ulcer decrease in the  population. 
Obviously many other factors also contribute to the production of 
PUD  other than Helicobacter pylori.Every patients who has H.pylori 
infection do not get peptic ulcer disease.only 10-15% of patients who are 
colonised with Helicobacter pylori will acquire PUD during  their life . 
Patients who are on aspirin and steroids  can develop PUD   without   
Helicobacter pylori infection.These  finally conclude that 
Helicobacterpylori is indoubtfully a critical factor in the formation and 
repetition of  PUD .Helicibacter pylori   play a critical role in the 
production of Stomach carcinoma  and lymphomas. 
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         A wide class  of abnormalities may be due to exposure  of acid to 
mucosal surface was  demonstrated in the individuals  with  ulcer. As a 
criteria   patients with ulcers in duodenum tend to produce  increased  
acid secretion  when compared with individuals  having stomach ulcer. It  
was noted that  ulcer in duodenum individuals have been a increased  
mean basal acid output than normal levels. 
Nocturnal secretion of acid is increased when compared with 
Secretion during morning hours .However most of the persons show their 
basal and peak outputs under normal limits and there is no relation  to  
acid  secretion  and nature  of the disease. Patients  with duodenal ulcer  
produce  increased secretion output to a secretary  stimulus than patients 
with normal controls .Even though duodenal ulcer patients usually have  
falling gastric levels normal. They can produce enormous amount of 
gastric acid in response to gastrin than normal individuals. 
Considering that patients with duodenal ulcer can produce 
excessive gastric acid.it has been said that that there are individuals have 
high falling gastrin levels.there is a decreased feedback mechanism in 
view that the parietal cell mass have increased sensitivity to gastrin.many 
of the long standing randomised trials have reasonably given a good 
understanding of acid and gastrin production in patients affected with 
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H.pylori infection.some individuals who have duodenal ulcer have an 
increased rate of gastric emptying which deliver an increased acid output 
to the duodenum.finallhy the buffering action of duodenal mucosa is 
diminished due to decreased production of bicarbonate secretion in 
individuals with peptic ulcer disease. 
In individuals who present with gastric ulcer the acid secretion is  
quite variable.currently stomach ulcers are divided according to the  
Modified Johnson classification. 
Type I-located near angularis incisuraris lesser curvature. 
Type II-associated with active or  quiesent  duodenal ulcer 
Type III-prepyloric disease 
Type IV-near gastroesophageal  junction 
Type V-medication induced can occur anywhere in stomach 
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MODIFIED JOHNSON CLASSIFICATION 
 
Individuals with gastric ulcer have decreased mucosal defences that  
lead to abnormal amount of acid back entry into mucosa producing  
injury.Duodenogastric reflex will lead to weaking of gastric mucosal  
defences. 
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GIANT DUODENAL  ULCERS 
These are a group of ulcers that might produce heavy morbidity in 
individuals. It is defined as a complete thickness defect that is 2 cm in 
length or greater in diameter and involves  a  greater portion of 
duodenum. These ulcers  were first described by  BRITZKA in 1931 that 
involve a greater part of duodenum 
Giant duodenal ulcers contribute to 1% of all duodenal ulcers and 
5% of all peptic ulcer disease which require emergency surgical 
interference. The ratio of male and female being affected is 3: 1. 
The main reason for giant duodenal ulcers are now recognised to be 
as the usage of Nsaids rather than h pylori. From the previous studies it 
has been clear that highest percentage of cases of giant duodenal ulcer is 
due to NSAIDS. 
Perforation due to giant duodenal ulcer is very critical due to 
excessive amount of destruction of duodenal tissue and a overwhelming 
sepsis occurs. 
Giant duodenal ulcers have a higher chance of post operative leak 
syndromes and gastric outlet obstruction. 
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ENDOSCOPICAL VIEW OF GASTRIC AND DUODENAL             
ULCERS 
 
MACROSCOPIC VIEW OF GASTRIC ULCER   WITH EVERTED  
 
       Edges of ulcer shows everted margins with a central crater   
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NSAIDs in peptic ulcer disease 
NSAIDs are inevitably linked to peptic ulcer disease .Individuals 
who are on  treatment for rheumatoid arthritis  and osteoarthritis take 
NSAIDs.these patients are affected to 10- 15% with PUD . The 
prevalence of peptic Ulcer disease  among persons who use NSAID  is 
about 24%. These involve 15%  mainly gastric  ulcer and 10% include 
duodenal disease PUD complaints such as  perforation and bleeding are 
more common in NSAID  users. most of  the patients are brought into 
focus only after facing  the  complications the risk of getting 
complications and adverse  effects in  patients using NSAID is higher 
when compared to  controls.The risk is higher and older age group. 
In old patients who are  under treatment using NSAIDs are likely to 
acquire an surgery relating  to GIT problem  is ten times when compared 
to normal subjects. It  was also found that the mortality rate in these  
individuals have increased to higher limit than the normal persons. They 
also have a  higher incidence of hospitalisation rate for  gastric intestinal  
problems than the normal subjects. 
Recently the increased usage of NSAID like aspirin has increased 
due to increase in cardiovascular accidents in the elderly.so these   
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patients must receive a concomitant acid suppression therapy if any  of 
the risk factors are found. 
Risk factors for usage of concomitant acid suppressive therapy 
1. ager over 80 
2. history of acid peptic disease 
3. concurrent steroid intake 
4. concurrent anticoagulant intake 
5. high dose NSAID 
Other factors 
A large number of epidemiological studies prove that persons who 
smoke  are  about two times more prone to develop PUD than non 
smokers.Smoking increases  acid output and increases duodenumgastric  
reflex.Smoking increases the amount of acid secretion and decreases 
prostaglandin secretion and bicarbonate secretion. Many studies have 
proven the relation of smoking to peptic ulcer   disease.Although difficult 
to measure plays  both physical and  psychological stress plays an 
important role in the treatment of  peptic ulcer disease. 
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In 1842 cushing decribed duodenal ulcer and duodenitis in burns 
patients later he explained the duodenal ulceration in the head injury 
patients later it was named as Cushing’s disease. 
Clinical manifestations 
More than 90% of the individuals with peptic  ulcer disease 
complain to have abdominal pain the pain is typically burning in   
character and usually localised to epigastrium the real cause of  pain is 
unclear the character of the pain is usually two to three hours  after having 
a meal. Majority of the patients will have a severe pain  which will make 
them to awake from sleep. Gastric ulceration pain  usually occurs during 
food intake and the pain usually subsides after  that. It does not awake the 
patient from sleep a careful history about  peptic ulcer disease, use of 
steroids and other anti secretary  medication is indicator of the diagnosis. 
Signs and symptoms 
-nausea 
-bloating  
-loss of weight 
-stool positive for occult blood 
-even anaemia 
-melena 
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 Duodenal ulcer usually occurs in male when compared to females 
gastric ulcer on the other hand do not have such a sex prediction and have 
a equal incidence in male and female patients. 
Diagnosis 
  In young individuals who complain of having dyspepsia or 
epigastric pain, it is enough to start an empirical dose of protein pump 
inhibitors to treat peptic ulcer disease without doing a confirmatory test in 
these case it is always necessary to inform the patients that there may be a 
little possibility of malignant lesion even of the symptoms of ulcer 
disease decrease markedly. In old individuals above 45 years of age must 
be subjected to an upper GI endoscopy all patients who have warning 
symptoms must undergo GI endoscopy irrespective of age. 
Alarming symptoms 
                       1.weight loss 
                       2.recurrent vomiting  
                       3.dysphagia 
                       4.bleeding 
                        5.anaemia 
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Investigation for peptic ulcer disease 
           - upper GI endoscopy 
           - biopsy 
           - a double contrast upper GI Xray 
           - any site of gastritis must be biopsised to rule out infection by 
Helicobacter pylori 
           - bottom line serum gastrin level to find out the possibility of 
gastrinoma 
Indications for diagnosis and treatment of H.pylori 
Established 
          Active peptic ulcer disease  
          Previous history of PUD not being treated for H.pylori 
          Low grade gastric mucosa associated lymphoid tissue 
After the resection of early gastric carcinoma by endoscopy 
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Controversial 
Non ulcer dyspepsia 
          GERD 
          Persons using steroids 
          Unexplained anaemia 
          Population at high risk for gastric carcinoma 
Tests for Helicobacter pylori 
         H.pylori has been known to produce peptic ulcer disease and has a 
role in gastric lymphoma and adenocarcinoma.there are a number of test 
to detect the presence of H.pylori.the positive predictive value of the test 
used for screening the H.pylori usually depends upon the prevalence of  
the H.pylori infection in the population to be investigated. 
A   positive    test  is   usually  holds good in saying the H.pylori  
infection in the locality but the negative predictive test is usually  
unreliable so in a clinical setting treatment  for H.pylori  infection  must 
be initiated on the basis of positive predictive value. 
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 Due to  strong association of  H.pylori infection with gastric 
lymphoma and  carcinoma many clinicians have recommended  treating 
of H.pylori  infection when their diagnosis is made. 
 
-a positive serological test is a direct evidence of active infection 
-histological examination of antral mucosal biopsy using special  
strains is the  standard test 
-RAPID UREASE TEST-to detect the presence of urease in 
mucosal biopsies 
Urease test is a strong evidence of infection with H.pylori.urease is 
a common enzyme that is found abundant in H.pylori strains.this urease 
enzyme is necessary for colonisation of H.pylori in the gastric mucosa. 
The labelled carbon-13  urea breath test  has been developed as a  
reasonable test to register the eradication of H.pylori after a  considerable 
treatment is given. 
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In this test urea is taken in food labelled with nonradioactive 
carbon-  13.This urea labelled is broken down by the urease produced in  
enormous amount by the H.pylori and they are divided into ammonia and 
carbon di oxide.the carbon di oxide radiolabelled is expired via the lungs 
and can be detected in the air expired.Blood sample can also be taken to 
detect the presence of radiolabelled carbondioxide Another test that is 
used is fecal antigen test which is quite sensitive  and specific for a 
overwhelming H.pylori infection 
 
Rapid urease test kit 
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The biopsy specimen is kept on the strip that contains urea,buffer 
and ph indicator.Since hpylori  contains excessive amount of urease it 
produces change in color in the ph indicator . The usefulness of the 
technique sis that it can be read within 3 hours. 
 
Histopathological examination of staining with urease kit 
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Complications of the peptic ulcer disease 
-bleeding 
-perforation 
-obstruction 
Causes of  upper GI bleeding 
Peptic ulcer disease is the most common cause for the upper GI 
Bleeding Patients who have upper GI bleeding must be admitted to 
hospital and resuscitated patients with bleeding ulcers have  symptoms of 
melena and  haematemesis.  
This can be confirmed by  nasogastric aspiration.abdominal pain 
can be a presenting  symptom .Profound blood loss patients may require a 
aggressive  resuscitation and blood transfusion. 
The best form of treatment is to diagnose and identify the cause of 
bleeding and arresting them .Nearly 75% patients admitted in hospital 
with PUD  bleeding will recover  if they are supplemented with acid 
suppressive therapy. However remainder of patients have a  tendency to 
rebleed. 
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The patients who have the tendency to rebleed depends upon the 
magnitude of the bleeding,age and endoscopic findings. 
High risk group patients  
-shocks 
-haemetemesis 
-transfusion  necessary for  4 units in 24 hrs 
-certain endoscopic stigmata 
          continuous bleeding 
          Visualised vessel 
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Increased  risk patients are usually benefitted from endoscopical  
therapy to  control active  bleeding. The  commonly used modalities are  
injection using  epinephrine. 
There are two important widely used risk stratification tools which 
has been found useful in predicting rebleeding and death  
Blantchford score 
Rockall score 
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Blatchford score 
At presentation                                                     score 
1.systolic BP 
100-109mm Hg                                                             1 
90-99mm Hg                                                                 2 
       <90mm Hg                                                                      3 
2. blood urea nitrogen 
6.5-7.9                                                                           2 
    8.0-9.9        3 
    10-24.9                                                                            4 
    >25                                                                                  6 
Hb                           men                        women 
                            12-12.9                       10-11.9                  1 
                             <10                             <10                       6 
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Other  variables  
                      Pulse >100 beats/min                                      1 
                      Melena                                                             1 
                      Syncope                                                           2 
                      Hepatic disease                                               2 
                      Cardiac failure                                                 2 
Rockall score 
Clinical                                                                          score 
Age 
        <60yrs                                                                     0 
          60-79yrs                                                                1 
          >80yrs                                                                   2 
Shock 
        Heart rate>100                                                       1 
        Systolic BP<100mm Hg                                           2 
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coexisting illness 
ischemic heart disease,                                                  2 
congestive cardiac failure                   
renal, hepatic failure                                                       3 
metastatic cancer 
endoscopic diagnosis 
no lesions observed,mallory weiss                               0 
Peptic ulcer,erosive disease                                          1 
cancer of upper GIT                                                      2 
endoscopic stigmata 
clean base ulcer,flat pigmented spot                            0 
blood in upper GIT active bleeding                               2 
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ENDOSCOPIC TREATMENT FOR BLEEDING: 
Bleeding ulcers can be treated endoscopically by a different 
number of ways. Nowadays the options has increased dramatically. 
Using endoscopic clips 
          Heater probe for coagulation of lumen 
          Epinephrine injected at the base  
          For diffuse areas of bleeding argon beam laser  
          Bicap probe  
Endoscopic arrest of ulcer bleeding requires various skill and good 
training in this field . The main difficulty in this technique is that it is very 
tough to see the bleeding vessel  through the scope when there is active 
bleeding. 
If the endoscopist fail  in controlling the bleeding Process or  the 
patient  rebleeds it is better to shift the patient  to Radiology or surgical  
department for further evaluation. If  however the  patient has been 
stabilised hemodynamically and again if he bleeds further another 
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endoscopy can be done to control the bleeding if no other large vessel is 
found to be bleeding which can detoriate the status of the individual. 
Perforation 
Perforated peptic ulcer usually present to the hospital as an    
abdominal emergency.The individual usually  gives the absolute period  
of  start of unbearable pain. 
Two phase 
                -chemical peritonitis; due to gastric and duodenal secretion 
                 -bacterial peritonitis 
As a result there is fluid sequestration in the third space resulting in  
dehydration and this would make recorrection using fluids a  mandatory 
situation.the patient would have symptoms of abdominal  pain and a very 
obvious distress can be seen 
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Air under diaprahgm 
Peritoneal signs of perforation  
-guarding 
          -rebound tenderness 
          -air under diaphragm 80% may be seen 
Once the diagnosis is made it may be resusicated  with normal 
saline and after sterilisation can be taken for surgery.Sometimes the 
perforation can get sealed by itself and surgery can be avoided.the sealed 
perforation can be confirmed by a radiological contrast study. 
Perforated  duodenal ulcer  actually  manifest as sudden increase in 
epigastric pain which may continue to affect the entire  abdomen 
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cavity.usually the pain is caused  by sudden gush of gastric contents into 
the peritoneal cavity  
This pain usually reaches a high intensity suddenly and then 
Afterwards  become a continuous pain which is aching in character with 
restriction of abdominal movements. 
There will be pain radiation to the right scapular region due to the 
fact that the released gastric contents occupy region of  right sub phrenic 
space. Peritoneal  contamination with irritation becomes very high and 
most patients will stay still to decrease their movements.The factors 
affecting the abdominal findings include 
size of defect in gastric mucosa 
          total content of organisms and secretions in peritoneum 
interval between onset and time during admission                               
spontaneous closure  
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PHYSICAL EXAMINATION 
Fever 
          Decreased intestinal peristalsis 
          Rigidity in anterior abdominal wall 
          There may be symptoms of  
          Shock  
          Tachycardia  
          Decreased  output in urine 
          Hypotension  
The other indicators of toxicity may not be found in patients who 
are  Severely immunocompromised and older individuals. The  
differential Diagnosis of perforation include 
Acute MI 
          Aortic dissection 
          Cholecystitis 
          Pancreatitis 
          Appendicitis 
          Renal colic 
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IMAGING MODALITIES 
Chest  xray pa view or a lateral decubitus xray to demonstrate free 
air which will be found in nearly 70 to 80% of individuals. Air under 
diaphragm is not only found in   duodenal or gastric ulcers it is also found 
in other hollow viscus perforation .Pneumoperitoneum is  present in 
larger amounts in a case of duodenal or gastric ulcers than other 
abdominal viscera.       
Upper  gastrointestinal study with water soluble contrast using  
Gastrograffin which will demonstrate release of contrast  through 
the defect 
 
Gastograffin contrast leak in xray 
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 Plain ct abdomen will show presence of free air in peritoneal 
cavity.  
CT with contrast may show leak of contrast from perforated site 
 
CT showing air in peritoneal cavity : pneumoperitoneum 
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RISK STRATIFICATION: 
            The overall risk factors contributing to the prognosis usually 
includes 
                Start of treatment after 24 hours 
                Hypotensive shock before surgery 
                Comorbid conditions 
TREATMENT 
Graham omental patch  repair is the most commonly performed   
Procedure  
Some patients may need further additional procedures  in certain 
circumstances 
Perforations usually greater than 2.0 cm may need THAL patch or 
they may require vagotomy,bill roth procedure and antrectomy 
Synchronous  bleeding  and  perforation  may need resection 
pyloroplasty,u stich control  
Chronic ulcer symptoms :patch closure with parietal cell vagotomy 
or pyloroplasty with ulcer excision Nsaids dependence : patch closure , 
parietal cell vagotomy, pyloroplasy or ulcer excision 
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Previous  h pylori   treatment failure :patch closure, parietal cell 
vagotomy,pyloroplasty and ulcer excision 
Previous ulcer complications :patch closure , parietal cell vagotomy  
pyloroplasty,and ulcer excision 
Obstruction 
Usually occur in about less than 5% of patients it may be usually  
due to a duodenal or  pre pyloric disease. The obstruction can develop   
due to inflammatory lesion and peristaltic dysfunction or  may be for 
longer periods  due to ulcer formation   
barium meal series showing distended stomach and accumulation 
of contrast within the stomach and deformed duodenal cap 
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CT ABDOMEN SHOWING GASTRIC OUTLET OBSTUCTION 
 
Signs and symptoms  
               1.non bilious vomiting 
               2.abdominal pain 
               3.profound hypokalemic hypocholermic metabolic alkalosis 
               4.weight loss 
Treatment 
               1.nasogastric suction 
               2.IV hydration 
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               3.anti secretory medication 
               4.diagnosis confirmed by endoscopy 
               5.May require a balloon dilation or surgery 
               6.malignancy has to be ruled out. 
Medical Management 
 ‘Proton pump inhibitors are the main stay of treatment in case of  
PUD.patients who are hospitalised for ulcer complication must be  given 
with a IV infusion of proton pump inhibitors these individuals  are 
candidates for lifelong PPI. peptic ulcer patients should quit  alcohol and 
smoking and NSAID use. 
Patients who definitely require a NSAID therapy must be given 
with addition of PPI.If H.pylori is found to be present it has to be treated 
adequately.  
Usually anti secretory drugs can be withdrawn  after  three 
months.if the  causative agents such as H.pylori,NSAID or aspirin is  
removed  misoprostol,sucralfate and acid suppression therapy can be  
accepted. 
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Treatment regimens for H.pylori 
Medication                                                                       duration 
PPI+clarithromycin 500mg+amoxicillin                        10-14 d                            
PPI+clarithromycin+mebonidazole                               10-14d 
PPI+amoxicillin,then                                                      5 days 
PPI+clarithromycin+tinidazole                                      5 days 
Other regimens 
Bismuth salicylate+metronidazole+tetracycline+PPI      10-14 days 
PPI+amoxicillin+levoflox                                                 10 days 
Surgical management 
The indications of the surgery in case of PUD is bleeding, 
perforation and obstruction and non healing ulcer.stomach carcinoma 
must be  kept in mind when treating patients with gastric ulcer or outlet 
obstruction. 
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Common procedures usually done is  
              Simple oversewing of a bleeding ulcer 
              Omental patch to a perforated ulcer 
              Distal gastrectomy 
During the past decades most  of the peptic ulcers was 
Satisfactorily  treated with 
Parietal cell vagotomy 
Vagotomy and drainage 
Vagotomy and distal gastrectomy 
Parietal cell vagotomy 
This is a safe procedure and saves nerve supply to upper one third  
of stomach in which the parietal cells are localised.this does not  involve 
the vagal supply to antrum and pylorus.this is the way the production of 
acid is decreased by 75%HSV is very useful in case of  gastric ulcer 
except in type II and type III ulcers because of  hypergastrenemia caused 
due to outlet obstruction and stasis in  antrum.the Taylor procedure 
65 
 
consists of a posterior truncal  vagotomy and includes anterior 
seromyotomy.     
Vagotomy and drainage procedures 
This includes truncal vagotomy and pyloroplasty and  
Gastrorejejunostomy. The greatest facility of V+D procedure is  that it 
can be performed in a fast and safety manner .Disadvantages include  
significant dumping and diarrhoea the main complication of this  
procedure to be kept in mind is the perforation of esophagus. 
It is useful in  
1.bleeding duodenal and gastric ulcer 
2.perforated duodenal and gastric ulcer 
3.obstructive duodenal and gastric ulcer(type II and III) 
The drainage procedures usually done in case of V+D procedures 
are  
Gastrojejunostomy 
Pyloroplasty 
Commonest   pyloroplasty   technique used is Heineke- 
Mikulicz type other types which are rarely used is Jaboulay 
pyloroplasty 
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Vagotomy and antrectomy 
This technique has a very low recurrence rate and is applicable to   all 
patients with peptic ulcer disease the ulcer is usually included  in the 
specimen removed and remaining  is established by Billroth  I and II 
gastrojejunostomy.Roux-en-y procedure is usually  avoided since this 
procedures leaves a stomach remnant of  about 60-70%.this procedure is 
usually done as a elective  procedure and its role in emergency is 
questionable and cannot  be done in patients with extensive inflammation. 
Surgical options in treatment of duodenal and gastric ulcer 
Indication            Duodenal                               Gastric 
Bleeding               1.oversew                             1.oversew biopsy 
                           2.oversew,V+D                      2.V+D 
                             3.V+A                                  3.distal gastrectomy 
Perforation              1.patch                         1.biopsy,patch 
                                2.patch,HSV                2.wedge excision,V+D 
                                3.patch V+D                3.distal gastrectomy 
 
Obstruction             1.HSV+GJ                1.biopsy,HSV+GJ 
                                2.V+A                       2.distal gastrectomy 
Non healing            1.HSV                           1.HSV and wedge excision 
                                2.V+D                 2.distal gastrectomy            
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The picture shows the anterior and posterior branch of vagus nerve 
and site where truncal vagotomy is done and site where highly  selective 
vagotomy is done  
 
ENDOSCOPIC VIEW OF DUODENAL ULCER DURING OGD 
ULCER IS SEEN IN THE FIRST PART OF DUODENUM.
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MATERIALS AND METHODS 
The study involves the patients who present to the department of  
general surgery with symptoms of dyspepsia subjecting to  endoscopy. 
Among these patients who are subjected to  endoscopy ,those who are 
having duodenal ulcer are taken into  study. 
After documentation of history, clinical examination involves  
general physical examination is done.During endoscopy the  stomach wall 
is examined and any changes in stomach wall is  noted .Endoscopically 
and biopsy from two areas in stomach is  taken from antrum and body and 
sent to histopathological  examination. 
          During histopathological examination the specimen is subjected  to 
rapid urease test to confirm the presence of H.pylori.the  histopathological 
changes are noted and the lesions are  recorded. 
Based on this study we analyze the incidence of different type of  
lesions such as chronic atropic gastritis,superficial pan gastritis in  these 
patients other than site of peptic ulcer disease and their  association with 
H.pylori. 
Exclusion criteria: carcinoma stomach ,gastric polyps, alcoholic 
gastritis. 
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RESULTS AND OBSERVATION 
AGE RELATED 
AGE % 
0-10 0 
10-20 0 
20-30 3 
30-40 20 
40-50 45 
50-60 25 
>60 7 
 
 
Here we are able to find that  incidence of cases is nearly 75 % in the 
age group between 40 to 50 years and duodenal ulcers are uncommon 
below 20 years of age 
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SEX RELATED 
NO.OF CASES MALE FEMALE 
60 40 20 
 
0
5
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35
40
45
60
MALE
FEMALE
 
The percentage of cases   affecting male was nearly 66.6% and in 
the female population it is nearly 33.3%.Hence  males are more prone to 
get peptic ulcer disease than woman 
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ASSOCIATION OF H.PYLORI 
NO.OF CASES RAPID UREASE 
POSITIVE 
RAPID UREASE 
NEGATIVE 
60 49 11 
 
 
The percentage of cases which were urease positive  in a  case of 
duodenal ulcer was nearly 87.6% and urease negative was 12.4%. Hence 
patients with duodenal ulcer  have been mostly colonised with h.pylori. 
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COMMONEST AREA TO BE AFFECTED 
NO.OF CASES ANTRUM BODY 
60 50 30 
 
 
The percentage of cases in which antrum was affected was nearly 
84% and 54% in body of stomach was affected by h pylori in nearly 50% 
of cases hence we found that antrum is the commonest site affected by 
hpylori 
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TYPE OF LESION 
NO.OF CASES CAG SG IM 
60 51 28 2 
 
 
CAG-CHRONIC ATROPIC GASTRITIS 
SG-SUPERFICICAL GASTRITIS 
IM-INTESTINAL METAPLASIA 
  The overall incidence of chronic atropic gastritis is nearly 84.1% 
when compared to other type of lesions. Hence it is the most commonest 
lesion caused by h.pylori. 
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DISCUSSION 
The study tells us about the incidence of H.pylori infection in 
patients having chronic duodenal ulcer and the different types of lesions  
found  endoscopically and proved histopathologically. Of the 60 patients 
under study 48 patients were found to be positive   for H.pylori using 
rapid urease test positive in antrial biopsy.20  patients were found to have 
been H.pylori positive in specimen with  biopsy from the body of the 
stomach. 
The histopathological findings on these were usually atropic  
gastritis, superficial  pangastritis and intestinal metaplasia. In antrum the 
commonest histopathological change was chronic  atropic gastritis nearly 
80% and the remaining showed  18.5%patients have superficial gastritis 
including the mucosa and  submucosa.nearly 1.5% patients showed the 
features of intestinal  metaplasia. 
Moreover patients were mainly males nearly 80%and females were 
20% affected due to H.pylori.the old individuals are mostly affected  than 
the younger population.the prevalence rate of H.pylori infection  in 
colonisation of stomach wall in antrum was nearly 92% and the  body 
showed colonisation in 46% of cases. 
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As a comparison to study conducted  by Dr jagmohan , in his study 
there were totally 100 patients in his study  of which there  74% males 
and 24% females affected .In our study percentage of males affected were    
66% and females were 33%. 
The  histological findings in that study was chronic gastritis of 
antrum was 93% and fundus was affected in 66% of cases.in our study the 
percentage is 92% and   42% respectively. 
The overall incidence percentage of chronic  atropic gastritis of  in 
that study was 82%  and percentage of cases in our study is 84%. 
Hence in both studies compared the percentage values correlate 
each other. 
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CONCLUSION 
Finally after conclusion from the study and comparing with 
previous  studies we are able to get the following results, 
the prevalence of H.pylori infection is more common in antrum 
than body of stomach 
the commonest histopathological change in the stomach wall 
produced by H.pylori is chronic gastritis which is of atropic type  
men are usually affected than women by H.pylori 
the elder population has higher incidence than the younger 
population. 
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PROFORMA 
CHANGES IN STOMACH WALL OTHER THAN SITES OF ULCER IN 
PEPTIC ULCER DISEASE. 
Patient details                                                             patient ID NO: 
Name: 
Age/sex: 
IP NO: 
DOA: 
DOE: 
Address: 
History  
   Occupation: 
   Socioeconomic status:upper/upper middle/lower middle/poor 
   ABDOMINAL PAIN:-           duration:-             onset:- 
   VOMITTING:-          duration:-         onset:- 
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INDIGESTION:- 
H/O DRUG INTAKE/ALCOHOLISM 
Family history: 
Past history:DM/HT/Asthma/TB/Other(surgery) 
General examination 
CONSIOUS 
   ORIENTED 
   AFEBRILE 
ICTERUS 
ANEMIC 
PR 
BP 
Examination of abdomen 
     EPIGASTRIC TENDERNESS:PRESENT/ABSENT 
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     MASS                                      :PRESENT/ABSENT 
Investigations 
Hb: 
TC: 
DC:P L E M 
ESR: 
Blood sugar: 
Blood urea:Serum creatinine: 
ENDOSCOPY: 
HISTOPATHOLOGICAL REPORT: 
     ANTRUM: 
     BODY: 
RAPID UREASE TEST:POSITIVE/NEGATIVE 
 
sl no NAME IP NO AGE SEX SYMPTOMS ENDOSCOPIC FINDINGS HISTOPATHOLOGICAL FINDING RAPID UREASE TEST
ANTRUM         BODY ANTRUM                BODY ANTRUM            BODY
1 loganathan 17840 72 m dyspepsia gastritis          gastritis  AG                           SG P                            P
2 rajeswari 18755 45 f abdominal pain  gastritis       normal AG                           NOMAL P                           N
3 SARAVAN 19131 40 M dyspepsia  gastritis       normal AG                           NOMAL P                            N
4 selvam 19084 42 m abdominal pain gastritis          gastritis AG                            AG P                            P
5 suresh 18891 28 m epigastric pain normal            normal  NORMAL             NORMAL N                            N
6 marimuthu 19001 46 M epigastric pain gastritis          gastritis AG                            SG P                            P
7 sundarraj 18686 55 m dyspepsia gastritis           normal SG                            NORMAL P                            N
8 ravi 19248 45 m epigastric pain  gastritis       normal SG                            NORMAL P                             N
9 sriman 19246 46 m dyspepsia gastritis          gastritis AG                           AG P                              P
10 siva 19254 46 m abdominal pain gastritis           normal SG                            NORMAL P                              N
11 rani 18908 45 f dyspepsia gastritis          gastritis  AG                           SG P                            P
12 shamth b 18996 45 f dyspepsia  gastritis       normal AG                           NOMAL P                           N
13 siva 19328 26 m epigastric pain  gastritis       normal AG                           NOMAL P                            N
14 ezhumalai 19252 40 m dyspepsia gastritis          gastritis AG                            AG P                            P
15 sekar 16179 45 m epigastric pain normal            normal  NORMAL             NORMAL N                            N
16 natarajan 18136 48 m dyspepsia gastritis          gastritis AG                            SG P                            P
17 palani 19253 70 m abdominal pain gastritis           normal IM                            NORMAL P                            N
18 viji 19488 40 f dyspepsia  gastritis       normal SG                            NORMAL P                             N
19 vinoth kumar 19489 53 m abdominal pain gastritis          gastritis AG                           AG P                              P
20 bhavan das 19521 71 m epigastric pain gastritis           normal SG                            NORMAL P                              N
21 ganesh raja 19856 38 m epigastric pain gastritis          gastritis  AG                           SG P                            P
22 sampath kumar 19816 42 m dyspepsia  gastritis       normal AG                           NOMAL P                           N
23 hussain 20509 34 m epigastric pain  gastritis       normal AG                           NOMAL P                            N
24 joseph 20501 50 m dyspepsia gastritis          gastritis AG                            AG P                            P
25 sivalingam 20517 38 m abdominal pain normal            normal  NORMAL             NORMAL N                            N
26 valliammal 19574 48 f dyspepsia gastritis          gastritis AG                            SG P                            P
27 govindsamy 20521 75 m dyspepsia gastritis           normal SG                            NORMAL P                            N
28 ravikumar 20018 45 m epigastric pain  gastritis       normal SG                            NORMAL P                             N
29 venkatasamy 19486 60 m dyspepsia gastritis          gastritis AG                           AG P                              P
30 mutthaia 19840 62 m epigastric pain gastritis           normal SG                            NORMAL P                              N
31 balu 19700 57 m dyspepsia gastritis          gastritis  AG                           SG P                            P
32 shanta 19828 38 f abdominal pain  gastritis       normal AG                           NOMAL P                           N
33 jagannathan 19076 60 m dyspepsia  gastritis       normal AG                           NOMAL P                            N
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34 koteswari 20017 48 f abdominal pain gastritis          gastritis AG                            AG P                            P
35 gurumoli 19988 60 f epigastric pain normal            normal  NORMAL             NORMAL N                            N
36 parthasarathi 20809 47 m epigastric pain gastritis          gastritis AG                            SG P                            P
37 neelavathi 20881 45 f dyspepsia gastritis           normal SG                            NORMAL P                            N
38 chinathambi 20011 66 m epigastric pain  gastritis       normal SG                            NORMAL P                             N
39 mahalingam 20727 54 m dyspepsia gastritis          gastritis AG                           AG P                              P
40 prabhu 20732 26 m abdominal pain gastritis           normal SG                            NORMAL P                              N
41 sofia 20513 23 f dyspepsia gastritis          gastritis  AG                           SG P                            P
42 jeyaraman 20522 70 m dyspepsia  gastritis       normal AG                           NOMAL P                           N
43 yamuna 20115 38 f epigastric pain  gastritis       normal AG                           NOMAL P                            N
44 nagavalli 20811 34 f dyspepsia gastritis          gastritis AG                            AG P                            P
45 balu 19700 57 m epigastric pain normal            normal  NORMAL             NORMAL N                            N
46 thiagarajan 21621 40 m dyspepsia gastritis          gastritis AG                            SG P                            P
47 deenathayalan 20939 46 m abdominal pain gastritis           normal SG                            NORMAL P                            N
48 palaniammal 21699 60 f dyspepsia  gastritis       normal SG                            NORMAL P                             N
49 mani 20904 45 m abdominal pain gastritis          gastritis AG                           AG P                              P
50 raja 21215 45 m epigastric pain gastritis           normal SG                            NORMAL P                              N
51 vijayalakshmi 21754 44 f epigastric pain gastritis          gastritis  AG                           SG P                            P
52 indrani 21751 55 f dyspepsia  gastritis       normal AG                           NOMAL P                           N
53 rahmath 21771 33 f epigastric pain  gastritis       normal AG                           NOMAL P                            N
54 sivananthan 21892 40 m dyspepsia gastritis          gastritis AG                            AG P                            P
55 govindsamy 18666 60 m abdominal pain normal            normal  NORMAL             NORMAL N                            N
56 eegan 20740 56 m dyspepsia gastritis          gastritis AG                            SG P                            P
57 sheela 21807 50 f dyspepsia gastritis           normal SG                            NORMAL P                            N
58 gangan 27073 46 m epigastric pain  gastritis       normal SG                            NORMAL P                             N
59 jeyasree 22084 42 m dyspepsia gastritis          gastritis AG                           AG P                              P
60 sreenivasan 22206 42 m epigastric pain gastritis           normal SG                            NORMAL P                              N
